169 related articles for article (PubMed ID: 25887043)
1. Radio-sensitization effect of an mTOR inhibitor, temsirolimus, on lung adenocarcinoma A549 cells under normoxic and hypoxic conditions.
Ushijima H; Suzuki Y; Oike T; Komachi M; Yoshimoto Y; Ando K; Okonogi N; Sato H; Noda SE; Saito J; Nakano T
J Radiat Res; 2015 Jul; 56(4):663-8. PubMed ID: 25887043
[TBL] [Abstract][Full Text] [Related]
2. Suppression of the proliferation of hypoxia-Induced retinal pigment epithelial cell by rapamycin through the /mTOR/HIF-1α/VEGF/ signaling.
Liu NN; Zhao N; Cai N
IUBMB Life; 2015 Jun; 67(6):446-52. PubMed ID: 25988388
[TBL] [Abstract][Full Text] [Related]
3. Intrinsically lower AKT, mammalian target of rapamycin, and hypoxia-inducible factor activity correlates with increased sensitivity to 2-deoxy-D-glucose under hypoxia in lung cancer cell lines.
Wangpaichitr M; Savaraj N; Maher J; Kurtoglu M; Lampidis TJ
Mol Cancer Ther; 2008 Jun; 7(6):1506-13. PubMed ID: 18566221
[TBL] [Abstract][Full Text] [Related]
4. Regulation of hypoxia-inducible factor-1α, regulated in development and DNA damage response-1 and mammalian target of rapamycin in human placental BeWo cells under hypoxia.
Zhou F; Guan LB; Yu P; Wang XD; Hu YY
Placenta; 2016 Sep; 45():24-31. PubMed ID: 27577706
[TBL] [Abstract][Full Text] [Related]
5. Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia.
Aquino-Gálvez A; González-Ávila G; Delgado-Tello J; Castillejos-López M; Mendoza-Milla C; Zúñiga J; Checa M; Maldonado-Martínez HA; Trinidad-López A; Cisneros J; Torres-Espíndola LM; Hernández-Jiménez C; Sommer B; Cabello-Gutiérrez C; Gutiérrez-González LH
Oncol Rep; 2016 Jan; 35(1):577-83. PubMed ID: 26548300
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of mTOR by temsirolimus contributes to prolonged survival of mice with pleural dissemination of non-small-cell lung cancer cells.
Ohara T; Takaoka M; Toyooka S; Tomono Y; Nishikawa T; Shirakawa Y; Yamatsuji T; Tanaka N; Fujiwara T; Naomoto Y
Cancer Sci; 2011 Jul; 102(7):1344-9. PubMed ID: 21521416
[TBL] [Abstract][Full Text] [Related]
7. Down regulation of mammalian target of rapamycin decreases HIF-1α and survivin expression in anoxic lung adenocarcinoma A549 cell to elemene and/or irradiation.
Zou K; Tong E; Xu Y; Deng X; Zou L
Tumour Biol; 2014 Oct; 35(10):9735-41. PubMed ID: 24972968
[TBL] [Abstract][Full Text] [Related]
8. Small interfering RNA targeting HIF-1α reduces hypoxia-dependent transcription and radiosensitizes hypoxic HT 1080 human fibrosarcoma cells in vitro.
Staab A; Fleischer M; Loeffler J; Said HM; Katzer A; Plathow C; Einsele H; Flentje M; Vordermark D
Strahlenther Onkol; 2011 Apr; 187(4):252-9. PubMed ID: 21437769
[TBL] [Abstract][Full Text] [Related]
9. Antiangiogenic potential of the Mammalian target of rapamycin inhibitor temsirolimus.
Del Bufalo D; Ciuffreda L; Trisciuoglio D; Desideri M; Cognetti F; Zupi G; Milella M
Cancer Res; 2006 Jun; 66(11):5549-54. PubMed ID: 16740688
[TBL] [Abstract][Full Text] [Related]
10. Oleanolic acid enhances the radiosensitivity of tumor cells under mimetic hypoxia through the reduction in intracellular GSH content and HIF-1α expression.
Qi R; Jin W; Wang J; Yi Q; Yu M; Xu S; Jin W
Oncol Rep; 2014 May; 31(5):2399-406. PubMed ID: 24604140
[TBL] [Abstract][Full Text] [Related]
11. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
12. Regulation of hypoxia-induced mRNA expressions of HIF-1alpha and osteopontin and in vitro radiosensitization by tirapazamine in human nasopharyngeal carcinoma HNE-1 and CNE-1 cells.
Xu P; Huang JM; Ren Y; Zha X; Deng BF; Wu JH; Lang JY
Chin J Cancer; 2010 Feb; 29(2):126-30. PubMed ID: 20109337
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative effect of a novel mTOR inhibitor temsirolimus contributes to the prolonged survival of orthotopic esophageal cancer-bearing mice.
Nishikawa T; Takaoka M; Ohara T; Tomono Y; Hao H; Bao X; Fukazawa T; Wang Z; Sakurama K; Fujiwara Y; Motoki T; Shirakawa Y; Yamatsuji T; Tanaka N; Fujiwara T; Naomoto Y
Cancer Biol Ther; 2013 Mar; 14(3):230-6. PubMed ID: 23291985
[TBL] [Abstract][Full Text] [Related]
14. [Mechanism of regulation of leptin expression in human lung adenocarcinoma cells by hypoxia inducible factor-1alpha: a preliminary study].
Zhang YB; Fang M; He FL; Hua TF; Hu BD; Zhao H; Liu RY
Zhonghua Yi Xue Za Zhi; 2008 Nov; 88(40):2848-53. PubMed ID: 19080496
[TBL] [Abstract][Full Text] [Related]
15. Activation of HIF-1alpha in exponentially growing cells via hypoxic stimulation is independent of the Akt/mTOR pathway.
Dayan F; Bilton RL; Laferrière J; Trottier E; Roux D; Pouyssegur J; Mazure NM
J Cell Physiol; 2009 Jan; 218(1):167-74. PubMed ID: 18781596
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-induced autophagy contributes to radioresistance via c-Jun-mediated Beclin1 expression in lung cancer cells.
Zou YM; Hu GY; Zhao XQ; Lu T; Zhu F; Yu SY; Xiong H
J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):761-767. PubMed ID: 25318890
[TBL] [Abstract][Full Text] [Related]
17. KNK437, abrogates hypoxia-induced radioresistance by dual targeting of the AKT and HIF-1α survival pathways.
Oommen D; Prise KM
Biochem Biophys Res Commun; 2012 May; 421(3):538-43. PubMed ID: 22521642
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of hypoxia inducible factor-1alpha in head and neck squamous cell carcinoma cell lines correlates with invasive potential.
Cohen NA; Lai SY; Ziober AF; Ziober BL
Laryngoscope; 2004 Mar; 114(3):418-23. PubMed ID: 15091212
[TBL] [Abstract][Full Text] [Related]
19. Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma.
Zhou Q; Lui VW; Lau CP; Cheng SH; Ng MH; Cai Y; Chan SL; Yeo W
Biochem Pharmacol; 2012 May; 83(9):1146-58. PubMed ID: 22285225
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma.
Miyazawa M; Yasuda M; Fujita M; Kajiwara H; Hirabayashi K; Takekoshi S; Hirasawa T; Murakami M; Ogane N; Kiguchi K; Ishiwata I; Mikami M; Osamura RY
Pathol Int; 2009 Jan; 59(1):19-27. PubMed ID: 19121088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
